Literature DB >> 16250652

Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.

Di-Fei Wang1, Paul Helquist, Norbert L Wiech, Olaf Wiest.   

Abstract

Histone deacetylases (HDACs) play an important role in gene transcription. Inhibitors of HDACs induce cell differentiation and suppress cell proliferation in tumor cells. Although many HDAC inhibitors have been designed and synthesized, selective inhibition for class I HDAC isoforms is a goal that has yet to be achieved. To understand the difference between class I HDAC isoforms that could be exploited for the design of isoform-specific HDAC inhibitors, we have built three-dimensional models of four class I histone deacetylases, HDAC1, HDAC2, HDAC3, and HDAC8. Comparison of the homology model of HDAC8 with the recently published X-ray structure shows excellent agreement and validates the approach. A series of HDAC inhibitors were docked to the homology models to understand the similarities and differences between the binding modes. Molecular dynamic simulations of these HDAC-inhibitor complexes indicate that the interaction between the protein surface and inhibitor is playing an important role; also some active site residues show some flexibility, which is usually not included in routine docking protocols. The implications of these results for the design of isoform-selective HDAC inhibitors are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16250652     DOI: 10.1021/jm0505011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  61 in total

1.  KDAC8 substrate specificity quantified by a biologically relevant, label-free deacetylation assay.

Authors:  Tasha B Toro; Terry J Watt
Journal:  Protein Sci       Date:  2015-10-07       Impact factor: 6.725

Review 2.  Discovery and mechanism of natural products as modulators of histone acetylation.

Authors:  Lilibeth A Salvador; Hendrik Luesch
Journal:  Curr Drug Targets       Date:  2012-07       Impact factor: 3.465

3.  Synthesis, molecular docking and biological evaluation as HDAC inhibitors of cyclopeptide mimetics by a tandem three-component reaction and intramolecular [3+2] cycloaddition.

Authors:  Tracey Pirali; Valeria Faccio; Riccardo Mossetti; Ambra A Grolla; Simone Di Micco; Giuseppe Bifulco; Armando A Genazzani; Gian Cesare Tron
Journal:  Mol Divers       Date:  2009-05-28       Impact factor: 2.943

4.  On the inhibition of histone deacetylase 8.

Authors:  Guillermina Estiu; Nathan West; Ralph Mazitschek; Edward Greenberg; James E Bradner; Olaf Wiest
Journal:  Bioorg Med Chem       Date:  2010-04-03       Impact factor: 3.641

5.  Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors.

Authors:  Joanna Fraczek; Sarah Deleu; Aneta Lukaszuk; Tatyana Doktorova; Dirk Tourwé; Albert Geerts; Tamara Vanhaecke; Karin Vanderkerken; Vera Rogiers
Journal:  Invest New Drugs       Date:  2008-09-30       Impact factor: 3.850

Review 6.  Isoform-selective histone deacetylase inhibitors.

Authors:  Anton V Bieliauskas; Mary Kay H Pflum
Journal:  Chem Soc Rev       Date:  2008-05-08       Impact factor: 54.564

7.  Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer.

Authors:  Andrew E Shouksmith; Fenil Shah; Michelle L Grimard; Justyna M Gawel; Yasir S Raouf; Mulu Geletu; Angelika Berger-Becvar; Elvin D de Araujo; H Artee Luchman; William L Heaton; David Bakhshinyan; Ashley A Adile; Chitra Venugopal; Thomas O'Hare; Michael W Deininger; Sheila K Singh; Stephen F Konieczny; Samuel Weiss; Melissa L Fishel; Patrick T Gunning
Journal:  J Med Chem       Date:  2019-03-06       Impact factor: 7.446

8.  Synthesis and histone deacetylase inhibitory activity of largazole analogs: alteration of the zinc-binding domain and macrocyclic scaffold.

Authors:  Albert A Bowers; Nathan West; Tenaya L Newkirk; Annie E Troutman-Youngman; Stuart L Schreiber; Olaf Wiest; James E Bradner; Robert M Williams
Journal:  Org Lett       Date:  2009-03-19       Impact factor: 6.005

9.  Identification of a better Homo sapiens Class II HDAC inhibitor through binding energy calculations and descriptor analysis.

Authors:  Usman Sumo Friend Tambunan; Evi Kristin Wulandari
Journal:  BMC Bioinformatics       Date:  2010-10-15       Impact factor: 3.169

10.  Binding ensemble profiling with photoaffinity labeling (BEProFL) approach: mapping the binding poses of HDAC8 inhibitors.

Authors:  Bai He; Subash Velaparthi; Gilles Pieffet; Chris Pennington; Aruna Mahesh; Denise L Holzle; Michael Brunsteiner; Richard van Breemen; Sylvie Y Blond; Pavel A Petukhov
Journal:  J Med Chem       Date:  2009-11-26       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.